1. Home
  2. XNCR vs BAND Comparison

XNCR vs BAND Comparison

Compare XNCR & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • BAND
  • Stock Information
  • Founded
  • XNCR 1997
  • BAND 2000
  • Country
  • XNCR United States
  • BAND United States
  • Employees
  • XNCR N/A
  • BAND N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • XNCR Health Care
  • BAND Technology
  • Exchange
  • XNCR Nasdaq
  • BAND Nasdaq
  • Market Cap
  • XNCR 547.8M
  • BAND 473.2M
  • IPO Year
  • XNCR 2013
  • BAND 2017
  • Fundamental
  • Price
  • XNCR $8.60
  • BAND $16.41
  • Analyst Decision
  • XNCR Buy
  • BAND Buy
  • Analyst Count
  • XNCR 10
  • BAND 6
  • Target Price
  • XNCR $23.33
  • BAND $20.80
  • AVG Volume (30 Days)
  • XNCR 700.0K
  • BAND 224.4K
  • Earning Date
  • XNCR 11-05-2025
  • BAND 10-30-2025
  • Dividend Yield
  • XNCR N/A
  • BAND N/A
  • EPS Growth
  • XNCR N/A
  • BAND N/A
  • EPS
  • XNCR N/A
  • BAND N/A
  • Revenue
  • XNCR $146,929,000.00
  • BAND $758,106,000.00
  • Revenue This Year
  • XNCR $22.06
  • BAND $2.48
  • Revenue Next Year
  • XNCR N/A
  • BAND $13.24
  • P/E Ratio
  • XNCR N/A
  • BAND N/A
  • Revenue Growth
  • XNCR N/A
  • BAND 14.51
  • 52 Week Low
  • XNCR $6.92
  • BAND $11.33
  • 52 Week High
  • XNCR $27.24
  • BAND $23.00
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 57.89
  • BAND 66.20
  • Support Level
  • XNCR $8.25
  • BAND $14.97
  • Resistance Level
  • XNCR $8.73
  • BAND $16.49
  • Average True Range (ATR)
  • XNCR 0.38
  • BAND 0.60
  • MACD
  • XNCR 0.07
  • BAND 0.15
  • Stochastic Oscillator
  • XNCR 78.76
  • BAND 96.50

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: